伴鼻息肉的慢性鼻窦炎生物治疗无应答者的组织病理学特征
该回顾性研究分析了257例接受功能性内镜鼻窦手术(FESS)的伴鼻息肉慢性鼻窦炎(CRSwNP)患者,其中20例术前使用生物制剂且症状和息肉负荷持续存在。无应答者组织嗜酸性粒细胞减少(<5/高倍视野)比例显著高于对照组(55% vs 31.2%,p=0.044),基底膜增厚比例也显著增高(100% vs 78.1%,p=0.019)。作者认为这些特征符合非2型CRSwNP,可能对生物制剂反应不佳。
要点
- 生物治疗无应答者组织嗜酸性粒细胞减少(<5/高倍视野)比例显著高于对照组(55% vs 31.2%,p=0.044)。
- 无应答者基底膜增厚比例显著高于对照组(100% vs 78.1%,p=0.019)。
- 其余11项组织病理学变量在两组间未达统计学显著差异。
核心结论
- 生物治疗无应答者的组织病理学表现为嗜酸性粒细胞减少和基底膜增厚,尤其低组织嗜酸性粒细胞符合非2型CRSwNP,可能对生物制剂难以应答。
- 结合FESS进行的组织病理学分析可能有助于临床医生理解持续症状负担需FESS的CRSwNP患者对生物制剂的反应。
研究设计与样本
- 回顾性综述,纳入257例接受FESS的CRSwNP患者。
- 生物治疗无应答组为既往使用生物制剂且症状和息肉负荷持续存在者;未处方生物制剂的CRSwNP患者为对照组。
- 收集人口学、合并症及包含13项变量的结构化组织病理学资料。
主要发现
- 257例CRSwNP患者中20例术前使用生物制剂:14例(70.0%)使用度普利尤单抗,1例(5.0%)使用美泊利珠单抗,1例(5.0%)使用奥马珠单抗,4例(20.0%)尝试过多种生物制剂。
- 生物治疗无应答组平均年龄45.8岁,对照组为50.4岁。
- 无应答者组织嗜酸性粒细胞减少(定义为<5/高倍视野)发生率显著增高(55% vs 31.2%,p=0.044)。
- 无应答者基底膜增厚发生率显著增高(100% vs 78.1%,p=0.019)。
- 其余11项变量未达统计学显著差异。
临床怎么用
- 作者认为,结合FESS进行的组织病理学分析可能有助于临床医生理解持续症状负担需FESS的CRSwNP患者对生物制剂的反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biologics are effective for chronic rhinosinusitis with nasal polyposis (CRSwNP) by reducing type 2 inflammation. Nonresponders often require functional endoscopic sinus surgery (FESS) and represent a challenging population potentially due to non-type 2 pathophysiology. This study characterizes the histopathologic features of biologic nonresponders. METHODS: A retrospective review of 257 CRSwNP patients undergoing FESS was conducted. The biologic nonresponder group included patients with prior biologic therapy who exhibited persistent symptoms and polyp burden. Those with CRSwNP not prescribed biologic therapy were selected as controls. Demographics, comorbidities, and structured histopathology consisting of 13 variables were collected. RESULTS: Of 257 CRSwNP patients, 20 were on biologics prior to FESS. Fourteen patients (70.0%) received dupilumab, one (5.0%) received mepolizumab, one (5.0%) received omalizumab, and four (20.0%) tried multiple biologics. The mean age for the biologic nonresponder group was 45.8 years compared to 50.4 years for the controls. Nonresponders had a significantly increased incidence of reduced tissue eosinophilia, defined as <5 per high power field (55% vs. 31.2%, p = 0.044) and increased basement membrane thickening (100% vs. 78.1%, p = 0.019). The remaining 11 variables did not reach statistical significance. CONCLUSION: Histopathologic analysis of biologic nonresponders demonstrates decreased eosinophilia and thickened basement membranes. These findings, particularly low tissue eosinophils, are consistent with a non-type 2 CRSwNP that may be recalcitrant to biologic therapies. Histopathologic analysis done in conjunction with FESS may aid clinicians in understanding response to biologic therapies in patients with CRSwNP who have persistent symptom burden necessitating FESS.
引用
- Baird AM, Masliah J, Filip P, et al. Histopathologic features of biologic therapy nonresponders in chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. 2023. PMID: 37792287. doi:10.1002/alr.23283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。